Improving the Glimepiride Efficacy in Type 2 Diabetes Treatment: A Review of the Potential Advantages and Disadvantages of Glimepiride as Hypoglycemic Oral Medication.
Type 2diabetes is a major health problem that affects the majority of advanced and developing countries at the same limit ,type 2 diabetes is characterized by insulin resistance which generated after metabolic syndrome induction due to weight gain and low physical activity ,also characterized by ins...
Saved in:
| Main Authors: | Gehad Abdelazeem Elshamy, Hany M El-Bassossy, Shimaa Elshazly, Nesreen Elkomy |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Zagazig University, Faculty of Pharmacy
2025-06-01
|
| Series: | Zagazig Journal of Pharmaceutical Sciences |
| Subjects: | |
| Online Access: | https://zjps.journals.ekb.eg/article_427593_d365649dd34ff8fe9f0030161df0865c.pdf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Modern antihyperglycemic therapy: safety and efficacy of glimepiride
by: Lyudmila Alexandrovna Ruyatkina, et al.
Published: (2012-06-01) -
Optimization of therapy of type 2 diabetes mellitus with the oral hypoglycemic agent glimepiride
by: Tatiana Ivanovna Romantsova, et al.
Published: (2010-03-01) -
Evaluation of fixed dose combination of glimepiride and metformin in patients with type 2 diabetes. Results of Russian observational study
by: Natalya Vladislavovna Zaytseva, et al.
Published: (2015-06-01) -
Efficacy and safety of glimepiride as initial treatment in Russian patients with type 2 diabetes mellitus
by: Alexander Sergeevich Ametov, et al.
Published: (2013-12-01) -
Comparisons of pharmacokinetics of glimepiride in combination with Ojeok-san versus glimepiride alone: an open-label, one-sequence, two-treatment controlled clinical study
by: Jongyoon Kim, et al.
Published: (2025-07-01)